

there are drug trials that cost more money than that. also this is not +4 months comparison new drug vs nothing this is new drug vs old drug. if AZ also got their IP then it’s a fire sale
here is study: https://ascopubs.org/doi/10.1200/JCO.2026.44.17_suppl.LBA8500










it’s not even known yet and they say so:
it was also only for late stage metastatic patients with a very specific mutation. now, since AZ has the rights, and they have money for trials, they can try to get a trial for earlier stages, and so this new better drug might be used for larger patient population while still patented. and that would be money printer